Reactivating the Body’s Natural Defenders: A Breakthrough in Cholangiocarcinoma Treatment

We are thrilled to announce that our latest research on enhancing the immune system’s ability to combat cholangiocarcinoma (bile duct cancer) has been accepted for publication in Biomedicine & Pharmacotherapy (Impact Factor: 6.9)! 🎉

Led by researchers at the Siriraj Center of Research Excellence for Systems Pharmacology (SiSP) in collaboration with expert partners, this study uncovers a promising strategy to restore immune function in this highly aggressive cancer. By reactivating the body’s natural defenses, this approach brings new hope for more effective treatments.

🔬 Read the full research highlight here: https://www.sisyspharm.org/highlights/reactivating-the-bodys-natural-defenders-a-new-hope-for-fighting-cholangiocarcinoma